Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Molecules ; 19(9): 13251-66, 2014 Aug 28.
Artigo em Inglês | MEDLINE | ID: mdl-25170948

RESUMO

Twelve hybrids derived from triclosan were obtained via Williamson etherification of O-triclosan alkyl bromide plus chalcone and O-coumarin or O-chromone alkyl bromide plus triclosan, respectively. Structures of the products were elucidated by spectroscopic analysis. The synthesized compounds were evaluated for antileishmanial activity against L. (V) panamensis amastigotes. Cytotoxic activity was also evaluated against mammalian U-937 cells. Compounds 7-9 and 17, were active against Leishmania parasites (EC50=9.4; 10.2; 13.5 and 27.5 µg/mL, respectively) and showed no toxicity toward mammalian cells (>200 µg/mL). They are potential candidates for antileishmanial drug development. Compounds 25-27, were active and cytotoxic. Further studies using other cell types are needed in order to discriminate whether the toxicity shown by these compounds is against tumor or non-tumor cells. The results indicate that compounds containing small alkyl chains show better selectivity indices. Moreover, Michael acceptor moieties may modify both the leishmanicidal activity and cytotoxicity. Further studies are required to evaluate if the in vitro activity against Leishmania panamensis demonstrated here is also observed in vivo.


Assuntos
Antiprotozoários/farmacologia , Chalconas/farmacologia , Cumarínicos/farmacologia , Leishmania/efeitos dos fármacos , Triclosan/análogos & derivados , Triclosan/farmacologia , Antiprotozoários/síntese química , Linhagem Celular Tumoral , Chalconas/síntese química , Cumarínicos/síntese química , Avaliação Pré-Clínica de Medicamentos , Humanos , Concentração Inibidora 50 , Leishmaniose/tratamento farmacológico , Triclosan/síntese química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA